Mimedx

MiMedx Group, Inc. is a biopharmaceutical company based in Marietta, Georgia, focused on developing and marketing regenerative biologics derived from human placental tissue allografts. Utilizing its proprietary PURION Process, the company employs aseptic processing techniques and terminal sterilization to create a range of allografts. Key products include EpiFix, a membrane designed for chronic wound treatment, and AmnioFix, which is used in surgical procedures. Other offerings consist of AmnioCord and EpiCord, dehydrated human umbilical cord allografts, and AmnioFill, a connective tissue matrix. MiMedx's products cater to various healthcare sectors, including wound care, burns, surgical applications, orthopedics, sports medicine, ophthalmics, and dentistry. The company distributes its products through a direct sales force, independent agents, and third-party representatives.

Christopher Cashman

Executive Vice President and Chief Commercial Officer

Douglas Rice

CFO, Finance

Ricci S.Whitlow

COO

2 past transactions

Stability Biologics

Acquisition in 2016
Stability Biologics, LLC is a Nashville-based company that specializes in providing human tissue products to the surgical, spine, and orthopedic sectors of the healthcare industry in the United States. The company has evolved from a medical implant distributor to a national provider of high-quality allografts, serving leading physicians, hospitals, and surgery centers. Stability Biologics develops a range of bioactive bone graft products and tissue allografts, which include structural and particulate bone, structural allografts, demineralized bone matrix, and skin products for burns and traumatic wound care. By offering these innovative products, Stability Biologics enables healthcare professionals to perform safe and effective surgical procedures.

Surgical Biologics

Acquisition in 2010
Surgical Biologics is a leading manufacturer of placental-based allografts, specializing in minimally manipulated synthetic tissues. Based in Kennesaw, Georgia, the company has developed and distributed over 30,000 products designed for soft tissue repair procedures. Its advanced tissue processing techniques ensure the creation of safe, reliable, and effective implants suitable for various surgical applications, particularly utilizing amnion membranes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.